Advisory
AHA: OIG Proposal Unlikely to Lower Drug Prices
A Department of Health and Human Services' Office of Inspector General proposal to change drug discount safe harbors under the federal anti-kickback statute would likely increase premiums for Medicare beneficiaries without addressing the nation's high and rising drug prices, the AHA said.
Key Resources
Related Resources
AHA Center for Health Innovation Market Scan
Letter/Comment